TUSTIN, Calif. – United Biologics, Inc., a global leader in silicone vasculature, today announced that it is expanding its line of arterial silicone vasculature with the entire venous system. This expanded product line will make available a wider breadth of United Biologics vessel technology for all of their customers as well as pave the way for new markets.
“We will continue to evolve the vasculature models we provide to customers so that their experience is always unique and reliable,” said United Biologics. The vessels made by United Biologics challenge physicians, engineers and sales teams with varying degrees of tortuosity through both normal and abnormal vasculature that is physiologically accurate, seamless and reusable.
Availability and Pricing
The new venous system line is launching with three vessels from the leg area including the Venous Femoral Iliacs, Upper Venous Leg Region and Lower Venous Leg Region, which are immediately available. United Biologics partners should contact their regional sales representative for promotional pricing. For additional information, visit www.unitedbiologics.com.
About United Biologics, Inc.
United Biologics Inc. manufactures and distributes the most physiologically accurate silicone replications of human vasculature on the market today, including common pathologies. We are silicone vessels specialists, driven to better equip medical professionals to train physicians, challenge medical device R&D and enhance product marketing techniques.
Public Relations Contact:
Mary Jartcky
United Biologics Inc.
714-258-7922
info@unitedbiologics.com